Abstract
The diffusion and metabolism of prednisolone 21-farnesylate were investigated in viable skin of the hairless mouse in vitro. The pro-drug ester was extensively metabolized in viable skin, while it was stable in the donor and receptor solutions. The rate of appearance of the prodrug and its metabolite prednisolone was markedly influenced by the direction of the skin placed between the in vitro diffusion half-cells. The rate of bioconversion of the prodrug was determined as a function of the distance from the surface of the skin. The prodrug was increasingly metabolized with the distance from the surface of the skin, indicating that the responsible enzymes are enriched in the lower layers of the viable skin. A model with linearly increasing enzyme activity in the viable skin accounts for the in vitro profiles of the diffusion/metabolism of the prodrug in the viable skin of hairless mouse.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Y. W. Chien. Transdermal Controlled Systemic Medications, Marcel Dekker, New York, 1987.
J. Drustrup, A. Fullerton, L. Christrup, and H. Bundgaard. Utilization of prodrugs to enhance the transdermal absorption of morphine. Int. J. Pharm. 71:105–116 (1991).
F. P. Bonina, L. Montenegro, P. DeCapraris, E. Bousquet, and S. Tirendi. 1-Allylazacycloalkan-2-one esters as prodrugs of indomethacin for improved delivery through human skin. Int. J. Pharm. 77:21–29 (1991).
P. Liu, W. I. Higuchi, W.-Q. Song, T. K. Bergstrom, and W. R. Good. Quantitative evaluation of ethanol effects on diffusion and metabolism of β-estradiol in hairless mouse skin. Pharm. Res. 8:865–872 (1991).
P. Liu, W. I. Higuchi, A.-H. Ghanem, T. K. Bergstrom, and W. R. Good. Quantitation of simultaneous diffusion and metabolism of β-estradiol in hairless mouse skin: Enzyme distribution and intrinsic diffusion/metabolism parameters. Int. J. Pharm. 64:7–25 (1990).
K. H. Valia, K. Tojo, and Y. W. Chien. Long-term permeation kinetics of estradiol. III. Kinetic analysis of the simultaneous skin permeation and bioconversion of estradiol esters. Drug Dev. Ind. Pharm. 11:1133–1174 (1985).
K. Tojo and A. R. C. Lee. Bioconversion of provitamin to vitamins C and E in skin. J. Soc. Cosmet. Chem. 38:333–339 (1987).
S. Momii, T. Suzuki, and K. Tojo. Percutaneous absorption of nicotine: In vitro experiment. Proc. 9th Kyushu Region. Meet. Jap. Pharm. Assoc. 2-A11 (1992), p. 47.
R. C. Wester and P. K. Noonan. Relevance of animal models for percutaneous absorption. Int. J. Pharm. 7:99–110 (1980).
T. Hikima, K. Yamada, A. Yamashita, and K. Tojo. Drug permeation across the skin accompanied by enzymatic metabolism. Drug Deliv. Syst. 7:453–457 (1992).
K. Tojo, C. C. Chiang, and Y. W. Chien. Drug permeation across the skin: Effect of penetrant hydrophilicity. J. Pharm. Sci. 76:123–126 (1987).
K. Tojo and L. T. Fan. Membrane moderated controlled release. Math. Biosci. 57:279–300 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tojo, K., Yamada, K. & Hikima, T. Diffusion and Metabolism of Prednisolone Farnesylate in Viable Skin of the Hairless Mouse. Pharm Res 11, 393–397 (1994). https://doi.org/10.1023/A:1018960920313
Issue Date:
DOI: https://doi.org/10.1023/A:1018960920313